Back to Awarded Treatment Trials


Awarded Trial: 13T-016

Grant ID

13T-016

Illness

schizophrenia

Primary Drug/Intervention

aspirin

Primary Dosage

500 mg/b.i.d.

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Weiser

Sample Size

160

Duration of Study Period for Each Subject

112 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Mark Weiser

Degree

MD

Center

N/A

Institution

Sheba Medical Center

Address

Tel Hashomer

City or Town

Ramat Gan

State or Province

N/A

Zip or Postal Code

52621

Country

Israel

Email Address

mweiser@netvision.net.il